{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113549","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.953668+00:00","generated_at":"2026-05-30T06:51:21.257223+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cellectar regains Nasdaq compliance after filing restated financials and Form 10-Q","bullets":["Received Nasdaq letter dated Oct 31, 2024 confirming compliance with Listing Rule 5250(c)(1).","Filed on Oct 29, 2024 restated audited financials for FY2022 and FY2023 and restated quarterly periods in 2022-2023.","Also filed restated Q1 2024 quarterly report (Form 10-Q/A) and regular Q2 2024 quarterly report (Form 10-Q).","Nasdaq noted the matter is now closed, removing delisting risk from late filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113549","json":"https://secwatch.observer/filing/0001104659-24-113549.json","markdown":"https://secwatch.observer/filing/0001104659-24-113549.md","text":"https://secwatch.observer/filing/0001104659-24-113549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924113549/0001104659-24-113549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924113549/tm2427349d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:51:21.257223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}